Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

Carestream Molecular Imaging unveils services, gel imaging systems

Carestream Molecular Imaging, a division of Carestream Health, has begun providing custom conjugation services for its Kodak X-Sight Nanospheres and Large Stokes Shift Dyes. In addition, the firm has released two new gel imaging systems to advance its popular line of Kodak Gel Logic Systems for in vitro applications in life science research laboratories.

Cardinal income falls 17 percent in Q1

Cardinal Health, a provider of healthcare products and services, has reported that its 2009 first quarter net income fell 17 percent, despite revenue increases, as a result of write-downs and restructuring charges.

Replacement sales, developing markets to keep fluoroscopy market afloat

Characterized by relative maturity and sluggish growth, the global fluoroscopy and mobile C-arms market is forecasted to crawl to 9,600 units worth $1.3 billion in 2012, according to a report from market research firm Global Industry Analysts (GIA).

JAMA: First 30 days post-MI carry risk of sudden cardiac death

While the overall risk of sudden cardiac death following MI has declined significantly in the past 30 years, there is an increased risk for the first month after having an MI. The risk after 30 days decreases unless patients develop heart failure, according to a study in the Nov. 5 issue of Journal of the American Medical Association.

Vital Images incurs losses in Q3; reduces work force

Vital Images, a provider of advanced visualization and analysis solutions, has reported a net loss for the 2008 third quarter, which ended Sept. 30, of $243,000, compared to a net income of $927,000 for the 2007 third quarter.

Group-practice costs outpace revenues driven by drugs, liability

Compounding economic pressures created by declining reimbursement and crushing administrative burdens, operating costs rose faster than revenue in many medical group practices in 2007, according to the Medical Group Management Association (MGMA).

EPIX pares down work force 23%, narrows research scope

EPIX Pharmaceuticals, a MR contrast agent developer, is reducing its cost structure by decreasing its work force by approximately 23 percent, and narrowing the current focus of its research and development efforts, effective immediately.

Cardiac Science debuts new stress test, e-reporting system

Cardiac Science, a provider of advanced cardiac diagnosis, resuscitation, rehabilitation and informatics products, has launched its new Quinton Q-Stress 4.0, a ninth generation diagnostic stress testing technology, and Quinton Q-Tel RMS 3.1, an electronic reporting system.

Around the web

GE HealthCare said the price of iodine contrast increased by more than 200% between 2017 to 2023. Will new Chinese tariffs drive costs even higher?

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.